Skip to main content

Industrial Apparatuses in Confrontation

From the series The struggle against coronavirus

According to the British analyst firm Airfinity, some 9.5 billion doses of Covid-19 vaccines will be produced worldwide in 2021. This number is double the annual production of all types of vaccines in the pre-pandemic era (5 billion, excluding oral polio, travellers’ and military vaccines), and can be compared with the requirement of 11.5 billion to immunise two-thirds of the world’s population [Airfinity, March 8th]. The development of vaccines has been exceptionally rapid, but manufacturing them on a large scale has encountered difficulties and delays. In 2020, only 4% of the expected doses were in fact produced [ibidem].

Production is concentrated in a limited number of countries, largely interdependent due to supply chains that cross state borders and continents. The World Bank identifies, among the producing countries, a Covid-19 vaccine producers club of 13 countries that manufacture both the active ingredient and its components. This exclusive Vaccine Club is also awarded 60% of the total Advance Purchase Agreements (APAs) — the advance purchase of vaccines — with pharmaceutical companies [World Bank, The Covid-19 vaccine production club, March 2021].

The World Bank’s concern is that aggressive forms of vaccine nationalism , by limiting exports, are disrupting global supply chains. For its part, the World Health Organization (WHO) fears that in much of the world, such as in Africa, vaccines will not arrive until 2023 or 2024.

Crippled internationalism

In June last year, the Global Vaccine Alliance (GAVI), together with the Coalition for Epidemic Preparedness Innovations (CEPI) and the WHO, launched the COVAX programme. It covers 192 countries, with the aim of ensuring equitable global distribution of vaccines, initially providing two billion doses, two-thirds free of charge, to 92 lower-income countries. Donations were in short supply and, two months into the vaccination campaign, COVAX had still not been able to deliver a single dose to the poorest countries [Financial Times, February 13th]. Initially conceived as a single clearing house for vaccine orders around the world, from which all countries, rich and poor, would procure their doses, notes the City newspaper, the program almost immediately foundered in the race for bilateral deals between the richest nations and the vaccine companies, and the priority allocation to domestic needs practised by countries like the United States, the UK and, more recently, even India.

Limited production, coupled with the supply dispute that has arisen between the European Commission and pharmaceutical companies — in particular with the Anglo-Swedish company AstraZeneca — has prompted several European leaders (and various scientific and political figures) to raise the issue of patents. The President of the European Council Charles Michel at the beginning of the year raised the possibility of the EU adopting ‘urgent measures’ — provided for in Article 122 of the Treaty — to impose ‘compulsory licensing’ on companies [Politico, February 3rd]. In fact, last December, the request made by some countries, including India and South Africa, for companies to waive patent exclusivity was rejected by the United States, the UK and the EU [The New York Times, December 25th].

The protection of intellectual property is regulated by the TRIPS (Trade Related Aspects of Intellectual Property Rights) agreement of the World Trade Organization (WTO). The amendment, adopted at the Doha Conference in 2001 and subsequently clarified, provides for the right of a state, in the event of a national health emergency, to produce (or have a third-party produce) a drug without the permission of the company holding the patent on the product or its manufacturing process. In 2017, two-thirds of the WTO membership had ratified the amendment, making it operational.

The compulsory licence could facilitate the entry of new companies into the market, but it still leaves the problem of production capacity for high-technology medicines (such as new vaccines) unsolved.

A kind of ‘vaccine internationalism’ is called for by many. Its realization presupposes, however, the overcoming of barriers and conflicts, commercial and otherwise, between states, and of competition between economic groups; it involves the pooling of resources and productive capacity, the coordination and direction of the global production of vaccines and their distribution according to public needs worldwide. At the very least, it means stripping vaccines of their characteristics of a commodity, which is the form in which the products of human labour are presented in the capitalist social system.

The critics of neoliberalism and globalization stop at the threshold of criticizing the very foundations of the capitalist socio-economic formation. They instead lash out at the excessive power of the banks or the greed of the multinationals, etc., and cultivate the illusion that it is possible to eliminate some of these most odious, but inevitable, forms of capitalism in its imperialistic maturity. Lenin called this wishful thinking.

Production sites for Covid-19 vaccines in the EU and the UK.

Production sites for Covid-19 vaccines in the EU and the UK. In some plants (highlighted in red) the biological active substance is produced, in others the final stages of production, such as bottling and packaging, are carried out. Some of the facilities belong to the company that owns the vaccine, while more than half belong to companies that work on behalf of third parties (CDMO, Contract Development and Manufacturing Organization). Four vaccines are licensed in the EU (BioNTech/Pfizer, Oxford/AstraZeneca, Moderna and J&J); the others are under review by regulatory bodies (CureVac and Novavax) or are still undergoing clinical trials.

Sources: EDJNet — European Data Journalism Network, March 5th, European Commission; corporate communications.

Industrial powers in confrontation

Airfinity calculates that at the end of March the production of Covid-19 vaccines stood at 229 million doses in China, 164 in the US, 125 in India, 110 in the EU (three quarters of which are in Germany, Belgium and the Netherlands), and 16 in the UK. China exported 48%, India 44% and the EU 42%. The USA and the UK have kept all of their doses for their domestic markets [Airfinity, March 24th].

Internal Market Commissioner Thierry Breton believes the EU is winning the industrial battle: producing — he writes — over 200 million doses of vaccines, reaching current levels of production in the US, and the Union’s annual production capacity is expected to reach 3 billion doses by the end of the year. Breton also lays claim to the Union’s role as a top exporter worldwide. At least two-thirds of the 30 million doses administered in Britain were produced in Europe, and the UK depends on the EU for the second dose [European Commission, Beating COVID-19: Scale-up of vaccine production in Europe, April 8th].

Breton refers to 53 production sites for Covid-19 vaccines in Europe. 26% of the facilities are located in Germany. Together with the Netherlands and Belgium, the three countries host 40% of the sites, which in some cases produce more than one type of vaccine. In fact, at least thirty or so plants are owned by companies working on behalf of third parties (CDMO, Contract Development and Manufacturing Organization), of around ten nationalities, mostly German, Spanish and American.

The EU, writes Breton, is an industrial power that is and intends to remain a global player, rejecting vaccine nationalism. The European Commission has, however, since last January, made exports of vaccines subject to authorization. The EU, comments The Economist, is torn between its reputation as champion of open markets and the needs of internal supply [March 27th].

There is an ongoing struggle between the metropolises over health. The production capacity of vaccines, as well as the organisational efficiency in carrying out vaccination strategies — a precondition for a less or more rapid economic recovery — is a measure of the overall strength of states in the global competition.

Lotta Comunista, April 2021

Popular posts from this blog

The Works of Marx and Engels and the Bolshevik Model

Internationalism Pages 12–13 In the autumn of 1895 Lenin commented on the death of Friedrich Engels: "After his friend Karl Marx (who died in 1883), Engels was the finest scholar and teacher of the modern proletariat in the whole civilised world. […] In their scientific works, Marx and Engels were the first to explain that socialism is not the invention of dreamers, but the final aim and necessary result of the development of the productive forces in modern society. All recorded history hitherto has been a history of class struggle, of the succession of the rule and victory of certain social classes over others. And this will continue until the foundations of class struggle and of class domination – private property and anarchic social production – disappear. The interests of the proletariat demand the destruction of these foundations, and therefore the conscious class struggle of the organised workers must be directed against them. And every class strugg...

“Polish Moment” at Risk

Internationalism No. 78-79, August-September 2025 Page 3 From the series European news In July, the strategic triangle of London-Paris-Berlin was strengthened with the Northwood Declaration, in which the United Kingdom and France signalled the possibility of coordinating the use of their nuclear weapons through the creation of a “Nuclear Steering Group”, and with the Kensington Treaty, an Anglo-German defence pact. These agreements complement the Franco-British agreements of Lancaster House and the Franco-German Treaty of Aachen. Although Poland signed the Treaty of Nancy with France in May 2025, it was excluded from the recent “E3” consultations, in which only the United Kingdom, France, and Germany participated. Nevertheless, the establishment of the new government led by Donald Tusk, the Civic Platform (PO) leader, in the October 2023 elections, after eight years of antagonism with Brussels under the Law and Justice Party (PiS)-dominated government, ha...

The Theoretical and Political Battles of Arrigo Cervetto I

From the introduction to Arrigo Cervetto’s Opere Scelte (“Selected Works”), soon to be published in Italy by Edizioni Lotta Comunista. I Arrigo Cervetto was the founder, theorist, and leader of Lotta Comunista. From his first involvement in the partisan war in 1943-44 until his death in February 1995, his more than 50 years of political activity can be summarised in around twenty key battles. It goes without saying that those struggles - aimed at the restoration and develop ment of Marxist theory on economics, politics, social change, and international relations - are the common thread running through this selection of his writings. His memoirs, Quaderni 198I82 (“Notebooks 1981-82”), provide an account of those battles up to 1980. First battle: the factory and the partisan war The son of emigrants to Argentina from Savona in Italy, Cervetto was born in Buenos Aires in April 1927, a circumstance that would later influence his thinking about international politics. His early for...

The Drone War

Internationalism No. 78-79, August-September 2025 Page 13 From the series War industry and European defence The Economist provides an illustration of how the use of unmanned and remotely piloted systems in warfare is expanding. In Africa, 30 governments are equipped with UAVs (unmanned aerial vehicles), or drones. In 2024, they were deployed 484 times in local wars in thirteen different countries, twice as frequently as the previous year, causing 1,200 deaths. The most widely used drone on the continent is the TB2, produced by the Turkish company Baykar, which has seen a decade of extensive use in conflicts across Syria, Azerbaijan-Armenia, and Ukraine. LBA Systems and MALE drones At the Paris Air Show in mid-June, an agreement was signed to establish LBA Systems, a joint venture between Baykar and Leonardo. The aim is to produce the Akinci and TB3 drones, the latter of which will be capable of taking off from helicopter carrier decks. The aircraft wil...

Cryptocurrencies, Tariffs, Oil and Spending in Trump’s Executive Orders

Internationalism No. 73, March 2025 Page 8 Douglas Irwin, economist and historian of American trade policy, writes for the Peterson Institute that the tariffs announced by Donald Trump, if implemented, would constitute a “historic event in the annals of US trade policy” and “one of the largest increases in trade taxes in US history. One has to go back almost a century to find tariff increases comparable”. Irwin limits himself to providing us with a historical dimension to the planned duties. But the bewilderment and turmoil created, especially among Washington’s allies, derives from the fact that the tariffs being brandished are accompanied by a hail of presidential decrees and declarations that mark a profound political discontinuity, both in the balance of internal institutional powers and in the balance of power between nations. The watershed was expected, but the speed and vehemence of the White House’s assaults are setting the scene for a change of era i...

The Unstoppable Force: Capital’s Demand for Migrant Labour

Internationalism No. 78-79, August-September 2025 Page 16 “Before Giorgia Meloni became Italy’s prime minister, she pledged to cut immigration. Since she has been in government the number of non-EU work visas issued by Italy has increased”. This is how The Economist of April 26th summarises the schizophrenia of their politics; and this is not only true in Italy: “Net migration also surged in post-Brexit Britain”. The needs of the economic system do not coincide with the rhetoric of parliamentarism. And vice versa. Schizophrenia and imbalances in their politics Returning to Italy, the Bank of Italy has pointed out that by 2040, in just fifteen years, there will be a shortage of five million people of working age, which could lead to an estimated 11% contraction in GDP. This is why even Italy’s “sovereignist” government is preparing to widen the net of its Immigration Flow Decree. The latest update, approved on June 30th, provides for the entry of almost ...

Price War in the US and EU

Internationalism No. 78-79, August-September 2025 Page 7 From the series Industry and pharmaceuticals The contention in the biopharmaceutical field between the two sides of the Atlantic addresses the issue of costs, in two different ways. In a letter to the Financial Times published on April 23rd, Vas Narasimhan and Paul Hudson, the CEOs of Swiss company Novartis and French company Sanofi respectively, presented a harsh diagnosis of the state of European biopharmaceuticals compared to their major competitors, the United States and China. Narasimhan, an American son of immigrants from Tamil Nadu, and Hudson, a Briton, head two of the world's ten largest pharmaceutical multinationals. The two executives see "a strong outlook for the US – thanks to policies and regulations conducive to fast and broad patient access to innovative medicines". In contrast, Europe, "while home to some of the most important biopharma companies in the world"...

Reckless Bets on Migrants in California

Internationalism No. 78-79, August-September 2025 Page 11 From the series Chronicles of the new American nationalism The tariffs imposed by President Donald Trump on allies, partners and opponents of the United States have opened a phase of negotiations with the affected countries and caused reactions from some key States. The legal opposition from almost all areas of the US poses a test: whether States, courts, and Congress can influence trade policy and constrain the expansion of executive powers. Amid conflicting rulings, the tariffs have been reinstated – an outcome that, The New York Times remarks, has “left Washington, Wall Street, and much of the world trying to discern the future of US trade policy”. California’s dispute with the federal government has expanded to immigration policy and the domestic use of military force. The political, economic, and power struggles overlap with the electoral dimension. The establishment remains critical of or ...

Battle Over Times for European Rearmament

Internationalism No. 78-79, August-September 2025 Pages 1 and 2 In current Anglo-Saxon vocabulary, appeasement stands for cowardly and illusory pacification, as exemplified by the Munich Agreement of 1938, which conceded to the dismemberment of Czechoslovakia without stopping the march towards world war. Were Shigeru Ishiba, Ursula von der Leyen, Emmanuel Macron, and Friedrich Merz really, as has been said, the Neville Chamberlains of the tariff war, accepting appeasement on the 15% tariff in an ignominious surrender to Donald Trump's blackmail? And has Trump really revealed himself in Anchorage, Alaska, to be an appeaser towards Vladimir Putin? Was it, finally, only the firmness of the Europeans at the Washington summit which convinced Trump to remain as one of the guarantors of Ukraine's security? The plague of television and social media diplomacy feeds on simplistic and propagandistic images, but also consumes and contradicts them at the pace of...

The Theoretical and Political Battles of Arrigo Cervetto II

From the introduction to Arrigo Cervetto’s Opere Scelte (“Selected Works”), soon to be published in Italy by Edizioni Lotta Comunista. II “Neither Washington nor Moscow”, “Neither Truman nor Stalin”. These were slogans sufficient to rally the internationalist cause, not only against the influence of the Stalinist Italian Communist Party (PCI) on one front, but also, on the opposite side, against the pro-American, “Westernist” leanings present in certain political currents of anarchist individualism. There was a unitary imperialism to be fought, of which the US and the USSR were both expressions. 1951, Genoa Pontedecimo In the ideological climate of the Cold War, heightened by the Korean War, a third world conflict was considered imminent; La guerra che viene (“The coming war”) was the title of a Trotskyist-inspired pamphlet that ultimately leaned in favour of the USSR, but reflected a widespread perception. The internation alist principle alone proved insufficient. To maintain...